Recent Quarter Total Invested
$240.07 M
Recent Quarter Institutional Ownership Percentage
87.14%
Total Invested of Last Quarter
$382.04 M
Ownership Percentage of Last Quarter
96.21%
Inozyme Pharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 21,427 | $95,564 | 14.36% | 0.03% |
JPMORGAN CHASE & CO | 08/12/2024 | 22,077 | $98,464 | -64.15% | 0.04% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 22,713 | $101,300 | 34.73% | 0.04% |
BAILARD, INC. | 07/25/2024 | 24,300 | $108,378 | 0.00% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 24,405 | $108,846 | 100.00% | 0.04% |
CITADEL ADVISORS LLC | 08/14/2024 | 25,895 | $115,492 | -72.07% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 08/14/2024 | 27,811 | $124,037 | 100.00% | 0.05% |
METLIFE INVESTMENT MANAGEMENT, LLC | 08/13/2024 | 27,949 | $124,653 | 45.52% | 0.05% |
TWO SIGMA ADVISERS, LP | 08/14/2024 | 29,600 | $132,016 | -28.33% | 0.05% |
ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 32,650 | $145,619 | 78.61% | 0.05% |
PALE FIRE CAPITAL SE | 08/13/2024 | 38,901 | $173,498 | 100.00% | 0.06% |
GSA CAPITAL PARTNERS LLP | 08/15/2024 | 40,931 | $183,000 | -68.78% | 0.07% |
JANE STREET GROUP, LLC | 08/15/2024 | 46,017 | $205,236 | 58.22% | 0.07% |
ALPS ADVISORS INC | 08/13/2024 | 48,263 | $215,253 | 10.80% | 0.08% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 55,186 | $246,000 | 100.00% | 0.09% |
AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 57,100 | $254,666 | 11.03% | 0.09% |
RHUMBLINE ADVISERS | 08/01/2024 | 77,004 | $343,426 | 21.96% | 0.12% |
MORGAN STANLEY | 08/14/2024 | 78,898 | $351,885 | -36.50% | 0.13% |
LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 126,541 | $564,373 | -68.54% | 0.20% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 140,022 | $624,498 | 133.78% | 0.23% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 143,158 | $638,485 | 13.14% | 0.23% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 160,879 | $717,520 | 0.00% | 0.26% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 187,839 | $837,762 | 8.14% | 0.30% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 190,896 | $851,397 | 16.09% | 0.31% |
UBS OCONNOR LLC | 08/14/2024 | 205,218 | $915,272 | 12.01% | 0.33% |
OVERBROOK MANAGEMENT CORP | 07/25/2024 | 219,326 | $978,194 | 0.00% | 0.36% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 232,980 | $1.04 M | -4.59% | 0.38% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 361,868 | $1.61 M | -11.72% | 0.59% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 380,064 | $1.70 M | 117.62% | 0.62% |
NORTHERN TRUST CORP | 08/14/2024 | 411,376 | $1.83 M | -2.03% | 0.67% |
KNOTT DAVID M JR | 08/12/2024 | 564,549 | $2.52 M | 0.00% | 0.91% |
STATE STREET CORP | 08/14/2024 | 1.00 M | $4.46 M | 13.56% | 1.62% |
WOODLINE PARTNERS LP | 08/14/2024 | 1.00 M | $4.46 M | 12.68% | 1.62% |
BLUE OWL CAPITAL HOLDINGS LP | 08/15/2024 | 1.12 M | $5.00 M | -11.81% | 1.81% |
SATURN V CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.14 M | $5.09 M | 100.00% | 1.85% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.15 M | $5.14 M | 7.89% | 1.86% |
SPHERA FUNDS MANAGEMENT LTD. | 08/14/2024 | 1.46 M | $6.52 M | 6.54% | 2.37% |
SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 1.56 M | $6.97 M | 0.00% | 2.53% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.79 M | $7.97 M | 154.11% | 2.89% |
NEA MANAGEMENT COMPANY, LLC | 08/14/2024 | 2.44 M | $10.87 M | 0.00% | 3.95% |
FMR LLC | 08/13/2024 | 2.48 M | $11.05 M | 25.92% | 4.01% |
VANGUARD GROUP INC | 08/13/2024 | 2.63 M | $11.73 M | 8.69% | 4.26% |
AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 2.86 M | $12.74 M | 8.09% | 4.62% |
BLACKROCK INC. | 08/13/2024 | 3.34 M | $14.91 M | 8.24% | 5.41% |
SAMLYN CAPITAL, LLC | 08/14/2024 | 3.35 M | $14.94 M | 15.02% | 5.42% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 3.70 M | $16.49 M | 0.47% | 5.99% |
EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 3.94 M | $17.56 M | 23.79% | 6.37% |
SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 4.28 M | $19.09 M | 0.00% | 6.93% |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2024 | 4.49 M | $20.05 M | 0.00% | 7.28% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 5.73 M | $25.55 M | 7.51% | 9.27% |
Inozyme Pharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of INZY shares?
During the previous two years, 110 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.73 M
Pivotal bioVenture Partners Investment Advisor LLC: 4.49 M
Sofinnova Investments, Inc.: 4.28 M
EVENTIDE ASSET MANAGEMENT, LLC: 3.94 M
Rock Springs Capital Management LP: 3.7 M
SAMLYN CAPITAL, LLC: 3.35 M
-
What percentage of Inozyme Pharma, Inc. stock is owned by institutional investors?
87.14% of Inozyme Pharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at INZY ?
Institutional investors have bought a total of 55.34 M shares in the last 24 months. This purchase volume represents approximately $286.12 M in transactions.